EP3464248

3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    23.5.2017
  • EP published:
    8.9.2021
  • EP application number:
    17724833.3
  • Max expiry date:
    22.5.2037
  • Title:
    3-OXO-2,6-DIPHENYL-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES

Timeline

Today
23.5.2017EP application
8.9.2021EP Publication

Owner

  • Name:
    Bayer Pharma Aktiengesellschaft
  • Address:
    Müllerstrasse 178, 13353 Berlin, DE
  • Name:
    Deutsches Krebsforschungszentrum (DKFZ)
  • Address:
    Im Neuenheimer Feld 280, 69120 Heidelberg, DE

Inventor

  • Name:
    SCHMEES, Norbert
  • Address:
    13469 Berlin, DE
  • Name:
    GUTCHER, Ilona
  • Address:
    10439 Berlin, DE
  • Name:
    IRLBACHER, Horst
  • Address:
    10405 Berlin, DE
  • Name:
    BADER, Benjamin
  • Address:
    13467 Berlin, DE
  • Name:
    ZHAO, Na
  • Address:
    Beijng 100076, CN
  • Name:
    PLATTEN, Michael
  • Address:
    69115 Heidelberg, DE
  • Name:
    ROEHN, Ulrike
  • Address:
    10115 Berlin, DE
  • Name:
    ZORN, Ludwig
  • Address:
    13509 Berlin, DE
  • Name:
    ROESE, Lars
  • Address:
    13465 Berlin, DE
  • Name:
    STOECKIGT, Detlef
  • Address:
    14471 Postdam, DE

Priority

  • Number:
    PCT/CN2016/083308
  • Date:
    25.5.2016
  • Country:
    WO
  • Number:
    PCT/CN2017/074408
  • Date:
    22.2.2017
  • Country:
    WO

Classification

  • Categories:
    A61K 31/50, A61P 43/00, A61P 37/06, C07D 237/16, C07D 237/20, C07D 405/12, C07D 403/12, A61P 35/00, A61P 37/02

Upload documents